当前位置: X-MOL 学术JAMA › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Digital Phenotyping
JAMA ( IF 120.7 ) Pub Date : 2017-10-03 , DOI: 10.1001/jama.2017.11295
Thomas R. Insel 1
Affiliation  

Traditionally, psychiatry has offered clinical insights through keen behavioral observation and a deep study of emotion. With the subsequent biological revolution in psychiatry displacing psychoanalysis, some psychiatrists were concerned that the field shifted from “brainless” to “mindless.”1 Over the past 4 decades, behavioral expertise, once the strength of psychiatry, has diminished in importanceaspsychiatricresearchfocusedonpharmacology,genomics, and neuroscience, and much of psychiatric practicehasbecomeaseriesofbriefclinical interactionsfocused on medication management. In research settings, assigning a diagnosis from the Diagnostic and Statistical Manual of Mental Disorders has become a surrogate for behavioral observation. In practice, few clinicians measure emotion, cognition, or behavior with any standard, validated tools. Some recent changes in both research and practice are promising. The National Institute of Mental Health has led an effort to create a new diagnostic approach for researchers that is intended to combine biological, behavioral, and social factors to create “precision medicine for psychiatry.”2 Although this Research Domain Criteria project has been controversial, the ensuing debate has been

中文翻译:

数字表型

传统上,精神病学通过敏锐的行为观察和对情绪的深入研究提供了临床见解。随着随后精神病学的生物学革命取代了精神分析,一些精神病学家担心该领域从“无脑”转向“无脑”1。在过去的 4 年里,行为专业知识曾经是精神病学的强项,但随着精神病学研究集中在药理学、基因组学、和神经科学,以及许多精神病学实践已经成为集中在药物管理上的一系列简短的临床互动。在研究环境中,根据《精神疾病诊断和统计手册》进行诊断已成为行为观察的替代方法。在实践中,很少有临床医生使用任何标准的、经过验证的工具来测量情绪、认知或行为。最近在研究和实践方面的一些变化是有希望的。美国国家心理健康研究所努力为研究人员创建一种新的诊断方法,旨在结合生物学、行为和社会因素来创建“精神病学精准医学”。2 尽管该研究领域标准项目一直存在争议,随后的辩论是
更新日期:2017-10-03
down
wechat
bug